Runar Vige

Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability

Abbie L. Cawood, Frances L. Napper, Ruth H. Young et al. · Atherosclerosis · 2010 · 242 citations

Life Sciences, Biochemistry, Cardiology +17

Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: A randomized, double-blind, placebo-controlled study

Marianne Thusgaard, Jesper Heile Christensen, Birgitte Mørn et al. · Scandinavian Journal of Infectious Diseases · 2009 · 46 citations

Life Sciences, Nutrition, Nutritional Sciences +15

Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial

Harold Bays, Jonas Hallén, Runar Vige et al. · Journal of clinical lipidology · 2015 · 31 citations

Medicine, Internal Medicine, Pharmacology +9

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients

Ta‐Chen Su, Juey‐Jen Hwang, Kuo‐Chin Huang et al. · Journal of Atherosclerosis and Thrombosis · 2016 · 16 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia

John J.P. Kastelein, Jonas Hallén, Runar Vige et al. · Cardiology · 2016 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17